Jonathan Schechter - 05 Jan 2026 Form 4 Insider Report for PharmaCyte Biotech, Inc. (PMCB)

Role
Director
Signature
/s/ Jonathan Schechter
Issuer symbol
PMCB
Transactions as of
05 Jan 2026
Net transactions value
+$48,232
Form type
4
Filing time
07 Jan 2026, 17:43:16 UTC
Previous filing
17 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SCHECHTER JONATHAN Director C/O PHARMACYTE BIOTECH, INC., 3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS /s/ Jonathan Schechter 07 Jan 2026 0001619259

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMCB Common Stock Purchase $15,552 +20,000 +15% $0.7776 152,500 05 Jan 2026 Direct
transaction PMCB Common Stock Purchase $15,808 +20,000 +13% $0.7904 172,500 06 Jan 2026 Direct
transaction PMCB Common Stock Purchase $16,872 +20,000 +12% $0.8436 192,500 07 Jan 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.